Shijiazhuang Yiling Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Shijiazhuang Yiling Pharmaceutical has a total shareholder equity of CN¥11.7B and total debt of CN¥1.4B, which brings its debt-to-equity ratio to 11.9%. Its total assets and total liabilities are CN¥17.1B and CN¥5.4B respectively. Shijiazhuang Yiling Pharmaceutical's EBIT is CN¥511.4M making its interest coverage ratio 191.3. It has cash and short-term investments of CN¥1.3B.
Key information
11.9%
Debt to equity ratio
CN¥1.40b
Debt
Interest coverage ratio | 191.3x |
Cash | CN¥1.30b |
Equity | CN¥11.74b |
Total liabilities | CN¥5.39b |
Total assets | CN¥17.13b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002603's short term assets (CN¥6.7B) exceed its short term liabilities (CN¥4.3B).
Long Term Liabilities: 002603's short term assets (CN¥6.7B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 002603's net debt to equity ratio (0.8%) is considered satisfactory.
Reducing Debt: 002603's debt to equity ratio has increased from 0% to 11.9% over the past 5 years.
Debt Coverage: 002603's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 002603's interest payments on its debt are well covered by EBIT (191.3x coverage).